Search
Menu
CLOSE
Search
You are about to leave the site
Close
J.P. Morgan Asset Management’s website and/or mobile terms, privacy and security policies don't apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan Asset Management isn’t responsible for (and doesn't provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan Asset Management name.
CONTINUE
Go Back
In this note, we highlight some of what we have posted recently, and which can be divided into issues the government can fix (credit availability and cost, income loss) and things it cannot (economic activity during a lockdown, the speed of medical advances).
- Trackers of high frequency US manufacturing and consumer data, which are harder to revive with Fed and fiscal policy when lockdowns are in place
- Trackers of the Fed's ability to reduce liquidity problems in credit markets, and where we see value
- A history of markets recovering before employment
- The Chloroquine controversy and the problem with non-randomized trials
- The limited value of infection prediction models (they usually don't work until you know the answer anyway)
Listen to the audio file or subscribe to the podcast to get the latest updates.
LISTEN AND SUBSCRIBE TO MICHAEL CEMBALEST
In this podcast series, Michael Cembalest, Chairman of Market and Investment Strategy offers timely commentary on the economy, marekts and investment portfolios
0903c02a8285fab2